Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2017 Nov 07

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

Minerva Medica 2017 Nov 07

DOI: 10.23736/S0026-4806.17.05349-6

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Polyphenol epigallocatechin-3-gallate inhibits hypoxia/reoxygenation-induced H9C2 cell apoptosis

Wenlong WANG 1, Xiaohui HUANG 1, Deliang SHEN 1, Zonghua MING 2, Mei ZHENG 3, Jinying ZHANG 1

1 Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Henan, China; 2 Health Management Center, People's Hospital of Zhangqiu, Jinan, Shandong, China; 3 Department of Medicine, People's Hospital of Zhangqiu, Jinan, Shandong, China


PDF  


BACKGROUND: We aimed to observe the protective effect of EGCG on hypoxia/reoxygenation injury of H9C2 myocardial cells and to study the inhibition mechanism of EGCG on hypoxia/reoxygenation injury of H9C2 myocardial cells.
METHODS: H9C2 cells were used as the objects of study and hypoxia/reoxygenation cells were pretreated with EGCG in different concentrations. MTT, Hoechst 33258 and LDH were used to detect the viability and apoptosis of H9C2 cells. The protection mechanism of polyphenol epigallocatechin-3-gallate was studied via western blotting and mitochondrial membrane potential detection.
RESULTS: Polyphenol epigallocatechin-3-gallate (10 μM) reduced the proportion of H9C2 cell apoptosis after hypoxia/reoxygenation (4/20 h), stabilized the mitochondrial membrane potential and decreased the expressions of mitochondrial damage-related proteins, thus protecting the mitochondrial function.
CONCLUSIONS: Polyphenol epigallocatechin-3-gallate alleviates the hypoxia/reoxygenation-induced H9C2 cell apoptosis, which may play the myocardial protective effect through inhibiting the mitochondrial Caspase pathway.


KEY WORDS: Polyphenol epigallocatechin-3-gallate - Hypoxia/reoxygenation - Mitochondrial membrane potential - Myocardial cells - Mitochondria

top of page

Publication History

Article first published online: November 07, 2017
Manuscript accepted: October 19, 2017
Manuscript received: July 17, 2017

Cite this article as

Wang W, Huang X, Shen D, Ming Z, Zheng M, Zhang J. Polyphenol epigallocatechin-3-gallate inhibits hypoxia/reoxygenation-induced H9C2 cell apoptosis. Minerva Med 2017 Nov 07. DOI: 10.23736/S0026-4806.17.05349-6

Corresponding author e-mail

pagap81@163.com